VICA — Omed Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $0.09m
- $0.41m
Annual income statement for Omed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.027 | 0.06 | 0.687 | 0.356 | 0.413 |
Cost of Revenue | |||||
Gross Profit | 0.01 | 0.028 | 0.366 | 0.226 | 0.268 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 18.9 | 9.12 | 2.29 | 3.26 | 6.26 |
Operating Profit | -18.8 | -9.06 | -1.61 | -2.9 | -5.84 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -19 | -9.44 | -1.61 | -2.91 | -5.85 |
Provision for Income Taxes | |||||
Net Income After Taxes | -19 | -9.44 | -1.6 | -1.22 | -5.85 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -19 | -9.44 | -1.6 | -2.99 | -5.85 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -19 | -9.44 | -1.6 | -2.99 | -5.85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.54 | -1.07 | -0.166 | -0.121 | -0.309 |
Dividends per Share |